-
Ferring strengthens growth hormone franchise Zomacton® through acquisition of ZomaJet™ needle-free injector device
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today that it has entered into a definitive agreement with Antares Pharma, Inc…
-
Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today that Professor Klaus Dugi has been appointed Executive Vice President and Chief Medical Officer…
-
Ferring announces new analysis of Rekovelle® data relating to personalised medicine in fertility patients
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today a new analysis of Rekovelle® (follitropin delta) data that showed cumulative live birth rates were similar…
-
Ferring appoints Lars Peter Brunse to Executive Board
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today that Lars Peter Brunse has been appointed Executive Vice President and Chief Production Officer…
-
Paul Navarre joins Ferring Pharmaceuticals as Chief Executive Officer of Ferring Holding Inc.
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today that Paul Navarre has been appointed Chief Executive Officer of Ferring Holding Inc…
-
Ferring appoints Aaron Graff to Executive Board
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer…
-
Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth
in PRESS RELEASE 2017 onFerring Pharmaceuticals and the March of Dimes Foundation announced today that Ferring has committed $10 million to support…
-
Ferring announces exclusive agreement with Alrise Biosystems for the development of an injectable, controlled-release peptide
in PRESS RELEASE 2017 onFerring Pharmaceuticals and Alrise Biosystems announced today that the companies have entered into a development agreement with…
-
Ferring highlights progress on social and environmental goals in Corporate Social Responsibility (CSR) Review 2015-2016
in PRESS RELEASE 2017 onFerring Pharmaceuticals releases its second Corporate Social Responsibility (CSR) review, highlighting progress on social and environmental goals…
-
Ferring appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer
in PRESS RELEASE 2017 onFerring Pharmaceuticals announced today that Dominic Moorhead has been appointed as Executive Vice President and Chief Financial Officer…
Author archive for pulse
Articles by: pulse
